peter attia on semaglutide 320 – AMA 64: New insights GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - The Drive dr peter attia semaglutide Peter

Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain

Developed by Eli Lilly and Company, it simultaneously targets GLP-1, GIP, and glucagon receptors a mechanism that distinguishes it from currently approved therapies such as semaglutide and tirzepatide

Glutathione infusions, on the other hand, take a targeted approach by fighting oxidative stress and inflammation directly

When your cells work better, you feel better

GLP-1s are not currently approved for longevity but can be prescribed off-label, including for microdosing

Losing weight may improve mood for some people, particularly if weight-related health problems or stigma were significant factors for them